Y150
/ YZY Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2025
A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=20 | Completed | Sponsor: Wuhan YZY Biopharma Co., Ltd. | Recruiting ➔ Completed | N=75 ➔ 20
Enrollment change • Trial completion • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1